16 results
6-K
EX-99.2
ASLN
ASLAN Pharmaceuticals Ltd
1 Mar 21
Current report (foreign)
4:02pm
Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review … and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing
424B5
ASLN
ASLAN Pharmaceuticals Ltd
9 Oct 20
Prospectus supplement for primary offering
5:03pm
other things, bring more transparency to drug pricing, review the relationship between pricing and
manufacturer patient programs, and reform government … , restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from
424B5
8ain3f
4 Dec 19
Prospectus supplement for primary offering
5:18pm
424B5
opksne4
2 Dec 19
Prospectus supplement for primary offering
5:29pm
F-3
b7eg4xx tq
31 Oct 19
Shelf registration (foreign)
4:09pm
F-1/A
9xrtdibdimy89
17 Jun 19
Registration statement (foreign) (amended)
4:04pm
F-1
p5s72oc
31 May 19
Registration statement (foreign)
12:00am
DRS
d9rcy4g0i27
17 May 19
Draft registration statement
12:00am
20-F
wwc3jk
29 Apr 19
Annual report (foreign)
9:34am
424B4
390fsqwe32
8 May 18
Prospectus supplement with pricing info
6:09am
424B4
flikwv9h vk
8 May 18
Prospectus supplement with pricing info
12:00am
F-1/A
suq1axjw491 au25r
1 May 18
Registration statement (foreign) (amended)
10:28am
- Prev
- 1
- Next